Ibrance | Description | MIMS Thailand

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing Brand Resources

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

IBRANCE 75 mg hard capsules: Each hard capsule contains 75 mg of palbociclib.
Excipients with known effect: Each hard capsule contains 56 mg of lactose (as monohydrate).
IBRANCE 100 mg hard capsules: Each hard capsule contains 100 mg of palbociclib.
Excipients with known effect: Each hard capsule contains 74 mg of lactose (as monohydrate).
IBRANCE 125 mg hard capsules: Each hard capsule contains 125 mg of palbociclib.
Excipients with known effect: Each hard capsule contains 93 mg of lactose (as monohydrate).
Excipients/Inactive Ingredients: Capsule content: Microcrystalline cellulose, Lactose monohydrate, Sodium starch glycolate type A, Colloidal anhydrous silica, Magnesium stearate.
Capsule shell: Gelatin, Red iron oxide (E172), Yellow iron oxide (E172), Titanium dioxide (E171).
Printing ink: Shellac, Titanium dioxide (E171), Ammonium hydroxide (28% solution), Propylene glycol, Simeticone.

Ibrance Description

palbociclib

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma

Marketer:

Pfizer